Paeds Vivas · neurology-neurodisability-and-neuromuscular
Headache and migraine in children: Viva
Branching clinical structured oral on headache and migraine in children: applying the ICHD-3 criteria, screening for SNNOOP red flags, building the acute abortive pathway, and defending the stepped prophylaxis in light of the CHAMP trial and the high paediatric placebo response.
On this page
Study tools
Target exams
Branch 1: Confirming the diagnosis
The candidate should confirm the diagnosis by applying the ICHD-3 criteria. This boy has had more than five attacks of headache lasting two to three hours, which falls within the two to 72 hour paediatric duration, with a throbbing quality, an intensity that forces him to stop and sleep (moderate to severe), and accompanying nausea and photophobia. He is fully well between attacks. These features meet the criteria for migraine without aura, and the family history of migraine in his father strengthens the diagnosis. A strong candidate notes that in children the pain is more often bilateral and frontotemporal, as it is here, and that the photophobia may be inferred from behaviour rather than reported. [1]
If the examiner presses on what else it could be, the candidate should distinguish migraine from tension-type headache, which is bilateral, pressing, mild to moderate, not worsened by activity, and lacks nausea, and should hold the boundary firmly. The key teaching point is that the diagnosis is clinical and that no investigation is needed once the criteria are met, provided the red-flag screen is negative. [1]
References4ShowHide
- [1]Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia, 2018.PMID 29368949
- [6]Powers SW, Coffey CS, Chamberlin LA, et al Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine. N Engl J Med, 2017.PMID 27788026
- [7]Powers SW, Kashikar-Zuck SM, Allen JR, et al Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial. JAMA, 2013.PMID 24368463
- [8]Richer L, Billinghurst L, Linsdell MA, et al Drugs for the acute treatment of migraine in children and adolescents. Cochrane Database Syst Rev, 2016.PMID 27091010